Crossmark

Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1016/j.htct.2021.09.020

Published Print: 2022-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Jafari, Mohammadali

Dastgheib, Seyed Alireza

Ferdosian, Farzad

Mirjalili, Hamid

Aarafi, Hossein http://orcid.org/0000-0003-0311-0582
Noorishadkam, Mahmood

Mazaheri, Mahta

Neamatzadeh, Hossein
License Information

Text and Data Mining valid from 2022-04-01

Text and Data Mining valid from 2022-04-01

Version of Record valid from 2021-12-11
More Information

This article is maintained by: Elsevier

Article Title: Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2021.09.020

Content Type: article

Copyright: © 2021 Published by Elsevier España, S.L.U. on behalf of Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.